Eyestem

Eyestem is a cell therapy company founded by a top-tier management team composed of experts in clinical trials, cell therapy, and ophthalmology. It develops scalable cell replacement therapies aimed at treating incurable diseases. The company’s platform focuses on replacing damaged photoreceptor cells in the eye with healthy transplantable cells derived from induced pluripotent stem cells to restore vision in patients suffering from conditions such as dry age-related macular degeneration, enabling healthcare professionals to provide treatment for patients.